SOX21 and cancer: SOX21-AS1 is highly expressed in various human cancers and may promote epithelo-mesenchymal transition and drug resistance in cancer, thus interfering with SOX21-AS1 may lead to increased sensitivity to chemotherapeutics and decreased metastasis formation [46,47].